MIR22HG suppressed gastric cancer progression through attenuating NOTCH2 signaling [20] MIR22HG repressed cell proliferation, migration and invasion in CCA by negatively regulating the Wnt/β-catenin signaling pathway [18]. This evidence concerns the gene MIR22HG and cholangiocarcinoma.